Prion diseases of humans and animals: Their causes and molecular basis

Annual Review of Neuroscience

Volumn 24, Issue , 2001, Pages 519-550

  Collinge, J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Creutzfeldt Jakob disease; Prion protein; Scrapie; Spongiform encephalopathy

Indexed keywords

PRION PROTEIN;

ALPHA HELIX; BRAIN SPONGIOSIS; CREUTZFELDT JAKOB DISEASE; GLYCOSYLATION; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; REVIEW; SCRAPIE;

ANIMALS; CATTLE; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS; PRION DISEASES; PRIONS; PROTEIN STRUCTURE, SECONDARY;

EID: 0034916581     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.neuro.24.1.519     Document Type: Review

References (169)

1. Stability constants of metal complexes
2. Does the agent of scrapie replicate without nucleic acid?
3. The exceptionally small size of the scrapie agent
4. Transmission dynamics and epidemiology of BSE in British cattle
5. The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain
6. Aminoacid polymorphism in human prion protein and age at death in inherited prion disease
7. Dietary transmission of bovine spongiform encephalopathy to mice
8. Intrinsic physiological and morphological properties of principal cells of the hippocampus and neocortex in hamsters infected with scrapie
9. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery
10. Non-genetic propagation of strain-specific properties of scrapie prion protein
11. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent
12. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy
13. Identification of a protein that purifies with the scrapie prion
14. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells
15. Normal host prion protein necessary for scrapie-induced neurotoxicity
16. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment
17. The cellular prion protein binds copper in vivo
18. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity
19. Normal prion protein has an activity like that of superoxide dismutase
20. Can Creutzfeldt-Jakob disease be transmitted by transfusion?
21. The epidemiology of Creutzfeldt-Jakob disease: Conclusion of a 15-year investigation in France and review of the world literature
22. Transmission of bovine spongiform encephalopathy and scrapie to mice: Strain variation and the species barrier
23. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent
24. Mice devoid of PrP are resistant to scrapie
25. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein
26. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene
27. Cellular isoform of the scrapie agent protein participates in lymphocyte activation
28. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease-and phospholipase-sensitive
29. + currents
30. Human prion diseases and bovine spongiform encephalopathy (BSE)
31. Variant Creutzfeldt-Jakob disease
32. Prion protein gene analysis in new variant cases of Creutzfeldt-Jakob disease
33. Inherited prion disease with 144 base pair gene insertion. II: Clinical and pathological features
34. Diagnosis of Gerstmann-Straussler syndrome in familial dementia with prion protein gene analysis
35. B lymphocytes in prion neuroinvasion: Central or peripheral players
36. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy - Authors' reply to Arya and Evans
37. Prion dementia without characteristic pathology
38. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease
39. Transmission of fatal familial insomnia to laboratory animals
40. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein
41. A new variant of prion disease
42. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD
43. Prion protein is necessary for normal synaptic function
44. Surgical treatment and risk of sporadic Creutzfeldt-jakob disease: A case-control study
45. Predicting the CJD epidemic in humans
46. La maladie dite tremblante du mouton est- elle inocuable?
47. Proteins can adopt totally different folded conformations
48. Selective neuronal targeting in prion disease
49. Prion protein expression in human leukocyte differentiation
50. Modelling the expected numbers of preclinical and clinical cases of bovine spongiform encephalopathy in Switzerland
51. Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen
52. Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection
53. Prion protein (PrP) with amino terminal deletions restoring susceptibility of PrP knockout mice to scrapie
54. Neurotoxicity of a prion protein fragment
55. Pharmacological rescue of mutant p53 conformation and function
56. Experimental transmission of a kuru-like syndrome to chimpanzees
57. Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain
58. Creutzfeldt-Jakob Disease (spongiform encephalopathy): Transmission to the chimpanzee
59. Self replication and scrapie
60. Scrapie and kuru
61. Localization of the mRNA for a chicken prion protein by in situ hybridization
62. Evidence of presynaptic location and function of the prion protein
63. Patch-clamp analysis of synaptic transmission to cerebellar Purkinje cells of prion protein knockout mice
64. +-currents in cerebellar Purkinje cells
65. Protease-resistant prion protein produced in vitro lacks detectable infectivity
66. Investigation of variant Creutzfeldt Jakob disease and other human prion disease with tonsil biopsy samples
67. The same prion strain causes vCJD and BSE
68. Species barrier independent prion replication in apparently resistant species
69. Molecular screening of sheep for bovine spongiform encephalopathy
70. Molecular analysis of ovine prion protein identifies similarities between BSE and an experimental isolate of natural scrapie, CH1641
71. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH
72. Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein
73. Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein structural studies using synthetic peptides
74. Structural mobility of the human prion protein probed by backbone hydrogen exchange
75. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome
76. Mutant prion proteins in Gerstmann-Sträussler-Sheinker disease with neurofibrillary tangles
77. Spontaneous neurodegeneration in transgenic mice with mutant prion protein
78. Congo red prolongs the incubation period in scrapie-infected hamsters
79. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations
80. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform
81. Spongiform encephalopathy in a nyala (Tragelaphus angasi)
82. Characteristics of a short incubation model of scrapie in the golden hamster
83. Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture
84. Pathogenesis of scrapie: Agent multiplication in brain at the first and second passage of hamster scrapie in mice
85. Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions
86. Spongiform encephalopathy in an arabian oryx (Oryx leucoryx) and a greater kudu (Tragelaphus strepsiceros)
87. Pathology of kuru
88. PrP expression in B-lymphocytes is not required for prion neuroinvasion
89. A crucial role for B cells in neuroinvasive scrapie
90. The natural incubation period of kuru and the episodes of transmission in three clusters of patients
91. Cell-free formation of protease-resistant prion protein
92. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: A model for the scrapie species barrier
93. Molecular analysis of bovine spongiform encephalopathy and scrapie strain variation
94. Neurotoxicity of prion peptide 106-126 not confirmed
95. The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system
96. Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein
97. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein
98. Lysosomes as key organelles in the pathogenesis of prion encephalopathies
99. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein
100. Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus
101. The prion protein gene: A role in mouse embryogenesis?
102. Epidemiological and experimental studies on a new incident of transmissible mink encephalopathy
103. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Straussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies
104. Protein processing in lysosomes: The new therapeutic target in neurodegenerative disease
105. Scrapie in sheep
106. Fatal familial insomnia: A second kindred with mutation of prion protein gene at codon 178
107. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene
108. Epidemiology of chronic wasting disease in captive Rocky Mountain elk
109. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation
110. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein Doppel
111. Recombinant scrapie-like prion protein of 106 amino acids is soluble
112. A cellular gene encodes scrapie PrP 27-30 protein
113. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease
114. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease
115. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins
116. Typing prion isoforms
117. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease
118. Experiments with scrapie with special reference to the nature of the agent and the pathology of the disease
119. Histopathological similarities between scrapie and cuprizone toxicity in mice
120. Copper stimulates endocytosis of the prion protein
121. Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters
122. Novel proteinaceous infectious particles cause scrapie
123. Molecular biology of prion diseases
124. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication
125. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells
126. NMR structure of the mouse prion protein domain PrP (121-231)
127. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques
128. Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity
129. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions
130. A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits
131. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells
132. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides
133. Die histopathologische forschung in der psychiatrie
134. Spongiform encephalopathy in free-ranging mule deer (Odocoileus hemionus), white-tailed deer (Odocoileus virginianus) and Rocky Mountain elk (Cervus elaphus nelson) in northcentral Colorado
135. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing
136. Prion protein selectively binds copper(II) ions
137. Prion protein of 106 residues creates an artificial transmission barrier for prion replication in transgenic mice
138. pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231)
139. Effectiveness of anthracycline against experimental prion disease in syrian hamsters
140. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro
141. Synthesis and trafficking of prion proteins in cultured cells
142. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity
143. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein
144. Altered circadian activity rhythms and sleep in mice devoid of prion protein
145. Strain-specific prion-protein conformation determined by metal ions
146. Brain copper content and cuproenzyme activity do not vary with prion protein expression level
147. A "unified theory" of prion propagation
148. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): An update
149. A novel progressive spongiform encephalopathy in cattle
150. Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein
151. A new prion controls fungal cell fusion incompatibility
152. Evidence for two prions in yeast: [URE3] and [PSI]
153. Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates
154. Bovine spongiform encephalopathy: Epidemiological studies
155. A new variant of Creutzfeldt-Jakob disease in the UK
156. Separation of scrapie prion infectivity from PrP amyloid polymers
157. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie
158. Chronic wasting disease of captive mule deer: A spongiform encephalopathy
159. A candidate marsupial PrP gene reveals two domains conserved in mammalian PrP proteins
160. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: A systematic analysis of predisposing mutations and allelic variation in the PRNP gene
161. Naturally occurring scrapie-like spongiform encephalopathy in five domestic cats
162. New variant Creutzfeldt-Jakob disease: Neurological features and diagnostic tests
163. Infectivity of scrapie prions bound to a stainless steel surface